Effect of Ruboxistaurin on Blood–Retinal Barrier Permeability in Relation to Severity of Leakage in Diabetic Macular Edema
Authors:
- 1 October 2005
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 46 (10) , 3855-3858
Abstract
Purpose. The purpose of the study was to investigate the effect of orally administered ruboxistaurin (RBX, LY333531), a selective protein kinase C β inhibitor, on the permeability of the blood–retinal barrier in patients with diabetic macular edema.Keywords
This publication has 7 references indexed in Scilit:
- Effect of Intensive Therapy on the Microvascular Complications of Type 1 Diabetes MellitusJAMA, 2002
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β InhibitorScience, 1996
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs—An Extension of the Modified Airlie House ClassificationOphthalmology, 1991
- Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathyGraefe's Archive for Clinical and Experimental Ophthalmology, 1990
- QUANTITATIVE VITREOUS FLUOROPHOTOMETRY APPLYING A MATHEMATICAL-MODEL OF THE EYE1985